ASAbhinav Sehgal

Abhinav Sehgal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abhinav Sehgal has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher James Haas

    MedStar Health Internal Medicine Residency Program, Baltimore, MD, USA Georgetown University School of Medicine, Washington, D.C., USA

    1 shared publication
  • Esana Pokhrel

    Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, USA

    1 shared publication
  • Mark C Mattar

    Division of Gastroenterology, MedStar Georgetown University Hospital, Washington, DC 20007, United States

    1 shared publication
  • Rohan Mandaliya

    Division of Gastroenterology, MedStar Georgetown University Hospital, Washington, DC 20007, United States

    1 shared publication
  • Soorya Aggarwal

    Division of Gastroenterology, MedStar Georgetown University Hospital, Washington, DC 20007, United States

    1 shared publication
  • Thomas Loughney

    Division of Gastroenterology, MedStar Georgetown University Hospital, Washington, DC 20007, United States

    1 shared publication

Latest Publications

  • Open Access

    Improving sessile serrated adenoma detection rates with high definition colonoscopy: A retrospective study

    by Abhinav Sehgal, Soorya Aggarwal, Rohan Mandaliya, Thomas Loughney, Mark C Mattar

    Sessile serrated adenomas (SSAs) are important premalignant lesions that are difficult to detect during colonoscopy due to poor definition, concealment by mucous caps, and flat appearance. High definition (HD) colonoscopy may uniquely aid in the detection of these inconspicuous lesions compared to standard definition (SD) colonoscopes. In the absence of existing clinical guidelines to obligate the use of HD colonoscopy for colorectal cancer screening in average-risk patients, demonstrating the benefit of HD colonoscopy on SSA detection rate (SSADR) may help strengthen the evidence to recommend its use in all settings. To evaluate the benefit of HD colonoscopy compared to SD colonoscopy on SSADR in average-risk patients undergoing screening colonoscopy. Data from screening colonoscopies for patients aged 50-76 years two years before and two years after the transition from SD colonoscopy to HD colonoscopy at our large, academic teaching center were collected. Patients with symptoms of colorectal disease, positive occult blood test, history of colon polyps, cancer, polyposis syndrome, inflammatory bowel disease or family history of colon cancer or polyps were excluded. Patients whose endoscopists did not perform colonoscopies both before and after scope definition change were also excluded. Differences in individual endoscopist SSADR, average SSADR, and overall SSADR with SD colonoscopy vs HD colonoscopy were also evaluated for significance. A total of 3657 colonoscopies met eligibility criteria with 2012 colonoscopies from the SD colonoscopy period and 1645 colonoscopies from the HD colonoscopy period from a pool of 11 endoscopists. Statistically significant improvements of 2.30% in mean SSADR and 2.53% in overall SSADR were noted with HD colonoscopy (P = 0.00028 and P = 0.00849, respectively). On the individual level, three endoscopists experienced statistically significant benefit with HD colonoscopy (+5.74%, P = 0.0056; +4.50%, P = 0.0278; +4.84%, P = 0.03486). Our study suggests that HD colonoscopy statistically significantly improves sessile serrated adenoma detection rate in the screening of average risk patients during screening colonoscopy. By improving the detection and removal of these lesions, adoption of HD colonoscopy may reduce the significant premalignant burden of sessile serrated adenomas.


  • Open Access

    Mollaret’s Meningitis: A Rare Entity

    by Abhinav Sehgal, Esana Pokhrel, Walter R. Castro, Christopher J. Haas

    We report on a patient with Mollaret’s meningitis to highlight the appropriate diagnostic criteria and benign prognosis without empiric antiviral therapy. An 83-year-old man with a history of aseptic meningitis of unknown etiology followed by full recovery presented with a two-day history of fevers, generalized weakness, and neurologic abnormalities. Cerebral spinal fluid (CSF) analysis demonstrated lymphocytic pleocytosis consistent with aseptic meningitis. Given his prior noninfectious aseptic meningitis and symptom-free interval, Mollaret’s meningitis was suspected and empiric treatment for herpes simplex viruses (HSV) encephalitis with acyclovir was deferred. All CSF studies, including polymerase chain reactions for HSV-1 and HSV-2, returned negative with clinical improvement by the fourth day of admission. For patients suspected to have Mollaret’s meningitis, lumbar puncture should be conducted promptly to facilitate diagnosis. Although several reports describe patients with CSF infection, the diagnosis of Mollaret’s meningitis should be reserved for noninfectious cases. In such cases, empiric antiviral therapy for HSV encephalitis may be deferred and complete recovery is expected.